Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

Go back to Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
(NASDAQ: ELTX) Delayed: 1.92 --0 (-0%)
Previous Close $1.92    52 Week High $ 
Open $1.95    52 Week Low $ 
Day High $1.97    P/E N/A 
Day Low $1.85    EPS $ 
Volume 175,963